![M‐EA (methotrexate, etoposide, dactinomycin) and EMA‐CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first‐line treatment of high‐risk gestational trophoblastic neoplasia - Singh - 2021 - International Journal of ... M‐EA (methotrexate, etoposide, dactinomycin) and EMA‐CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first‐line treatment of high‐risk gestational trophoblastic neoplasia - Singh - 2021 - International Journal of ...](https://onlinelibrary.wiley.com/cms/asset/dc67d0d5-30b4-4fae-8cb1-698231cb106f/ijc.v148.9.cover.jpg?trick=1679922084888)
M‐EA (methotrexate, etoposide, dactinomycin) and EMA‐CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first‐line treatment of high‐risk gestational trophoblastic neoplasia - Singh - 2021 - International Journal of ...
![Efficacies of FAEV and EMA/CO regimens as primary treatment for gestational trophoblastic neoplasia | British Journal of Cancer Efficacies of FAEV and EMA/CO regimens as primary treatment for gestational trophoblastic neoplasia | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-022-01809-3/MediaObjects/41416_2022_1809_Fig1_HTML.png)
Efficacies of FAEV and EMA/CO regimens as primary treatment for gestational trophoblastic neoplasia | British Journal of Cancer
![Factors affecting remission to salvage chemotherapy with Etoposide-Cisplatin/Etoposide-Methotrexate-Actinomycin D (EP-EMA regimen) among chemoresistant high-risk Gestational Trophoblastic Neoplasia patients admitted in a tertiary institution: A 10-year ... Factors affecting remission to salvage chemotherapy with Etoposide-Cisplatin/Etoposide-Methotrexate-Actinomycin D (EP-EMA regimen) among chemoresistant high-risk Gestational Trophoblastic Neoplasia patients admitted in a tertiary institution: A 10-year ...](https://www.pogsjournal.org/articles/2021/45/4/images/PhilippJObstetGynecol_2021_45_4_135_329048_t3.jpg)
Factors affecting remission to salvage chemotherapy with Etoposide-Cisplatin/Etoposide-Methotrexate-Actinomycin D (EP-EMA regimen) among chemoresistant high-risk Gestational Trophoblastic Neoplasia patients admitted in a tertiary institution: A 10-year ...
![PDF] Management of EMA-CO resistant/refractory gestational trophoblastic neoplasia | Semantic Scholar PDF] Management of EMA-CO resistant/refractory gestational trophoblastic neoplasia | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c6294411822390428401c143e653815f964722b3/5-Table6-1.png)
PDF] Management of EMA-CO resistant/refractory gestational trophoblastic neoplasia | Semantic Scholar
![Efficacies of FAEV and EMA/CO regimens as primary treatment for gestational trophoblastic neoplasia | British Journal of Cancer Efficacies of FAEV and EMA/CO regimens as primary treatment for gestational trophoblastic neoplasia | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-022-01809-3/MediaObjects/41416_2022_1809_Fig1_HTML.png)
Efficacies of FAEV and EMA/CO regimens as primary treatment for gestational trophoblastic neoplasia | British Journal of Cancer
![PDF] Management of EMA-CO resistant/refractory gestational trophoblastic neoplasia | Semantic Scholar PDF] Management of EMA-CO resistant/refractory gestational trophoblastic neoplasia | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c6294411822390428401c143e653815f964722b3/4-Table2-1.png)
PDF] Management of EMA-CO resistant/refractory gestational trophoblastic neoplasia | Semantic Scholar
![PDF) Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia | Gokhan Tulunay and Nurettin Boran - Academia.edu PDF) Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia | Gokhan Tulunay and Nurettin Boran - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/48286911/mini_magick20190204-2865-nlv0kn.png?1549299662)
PDF) Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia | Gokhan Tulunay and Nurettin Boran - Academia.edu
![PDF] EMA‐EP regimen, as firstline multiple agent chemotherapy in high‐risk GTT patients (stage II–IV) | Semantic Scholar PDF] EMA‐EP regimen, as firstline multiple agent chemotherapy in high‐risk GTT patients (stage II–IV) | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d57b8773a05d411e67c2aebb28c3584ed0a23397/2-Table1-1.png)
PDF] EMA‐EP regimen, as firstline multiple agent chemotherapy in high‐risk GTT patients (stage II–IV) | Semantic Scholar
![PDF] Management of EMA-CO resistant/refractory gestational trophoblastic neoplasia | Semantic Scholar PDF] Management of EMA-CO resistant/refractory gestational trophoblastic neoplasia | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c6294411822390428401c143e653815f964722b3/4-Table4-1.png)